TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/07/2025
Voltar para busca
Dado oficial do USPTO
NITYR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
64
Atualização mais recente
23/07/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 35, 44
Data de depósito
11/09/2017
Data de registro
02/04/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
21/05/2025
Última transação
23/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
705
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Primeiro uso
01/08/2017
Primeiro uso no comércio
01/08/2017
Código do desenho
4
Tipo de titular
03
Localização do titular
Cambridge, GB
Examinador
BELENKER, ESTHER
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Cycle Pharmaceuticals Ltd.
Representantes
Jaclyn Elizabeth Diffley STOBBS
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
(Based on 44(e)) Pharmaceutical agents for the treatment of disorders of the metabolism and digestive systempharmaceutical agents for the treatment of tyrosinemia and hypertyrosinemiaall in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; parts and fittings for all of the aforementioned goods.; pharmaceutical preparations for the treatment of disorders of the metabolism and digestive systempharmaceutical preparations for the treatment of tyrosinemia and hypertyrosinemiaall in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; pharmaceuticals for the treatment of disorders of the metabolism and digestive systempharmaceuticals for the treatment of tyrosinemia and hypertyrosinemia all in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; Veterinary preparations for treatment of intestinal bacteria; veterinary preparationsantioxidants; veterinary preparations namelypain relief medications; veterinary preparations for treatment of chronic illnesses; veterinary preparations for treatment of viral diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for humans and animals supplements for the treatment of disorders of the metabolism and digestive systemsupplements for the treatment of tyrosinemia and hypertyrosinemiaall in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; (Based on Use in Commerce) food for babies; medical dressings; plasters for medical purposes; material for stopping teethdental wax; disinfectants; preparations for destroying vermin; fungicidesherbicides; biological preparations for the treatment of disorders of the metabolism and digestive systembiological preparations for the treatment of tyrosinemia and hypertyrosinemiaall in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; chemical preparations for the treatment of disorders of the metabolism and digestive systemchemical preparations for the treatment of tyrosinemia and hypertyrosinemiaall in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticalsdrug delivery agents for use in pharmaceuticalsdrugs and medicines for the treatment of disorders of the metabolism and digestive systemdrug delivery agents for use in pharmaceuticalsdrugs and medicines for the treatment of tyrosinemia and hypertyrosinemiaall in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; drugs for the treatment of rare diseasesin particular for the treatment of disorders of the metabolism and digestive systemdrugs for the treatment of rare diseasesin particular for the treatment of tyrosinemia and hypertyrosinemiaall in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; enzyme preparations for medical purposesenzyme preparations for the treatment of disorders of the metabolism and digestive systemenzyme preparations for the treatment of tyrosinemia and hypertyrosinemiamedical enzyme preparations in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; enzyme preparations for veterinary purposes; medical preparations for the treatment of disorders of the metabolism and digestive systemsmedical preparations for the treatment of tyrosinemia and hypertyrosinemiaall in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; medicines for the treatment of disorders of the metabolism and digestive systemmedicines for the treatment of tyrosinemia and hypertyrosinemiaall in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches
Classe 35
(Based on 44(e)) Advertising services; marketing services; business management; business administration services; providing office functions; advertising and marketing relating to medical and pharmaceutical goods and services; advertising and marketing relating to pharmaceuticalsmedicines and supplements for the treatment of disorders of the metabolism and digestive system; advertising and marketing relating to pharmaceuticalsmedicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; advertising and marketing relating to pharmaceuticalsmedicines and supplements for the treatment of rare diseases; business information in the field of pharmaceuticalsmedicines and supplements for the treatment of disorders of the metabolism and digestive system; business information in the field of pharmaceuticalsmedicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; business information in the field of pharmaceuticalsmedicines and supplements for the treatment of rare diseases; business information in the field of pharmaceuticalsmedicines and supplements; providing business information; on-line wholesale store services featuring pharmaceuticalsmedicines and supplements for the treatment of rare diseases; on-line wholesale store services featuring medical and pharmaceutical goods and services; on-line wholesale store services featuring pharmaceuticalsmedicines and supplements for the treatment of disorders of the metabolism and digestive system; on-line wholesale store services featuring pharmaceuticalsmedicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; promoting the goods and services of others via the internet in the medical and pharmaceutical industries; promoting the goods and services of others via the internet; retail pharmacy and drugstore services; retail store services featuring pharmaceuticalsmedicines and supplements for the treatment of disorders of the metabolism and digestive system; retail store services featuring pharmaceuticalsmedicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; retail store services featuring pharmaceuticalsmedicines and supplements for the treatment of rare diseases; retail store services featuring pharmaceuticalsmedicines and supplements in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches
Classe 44
(Based on 44(e)) Medical services; veterinary services; hygienic and beauty care for human beings or animals; horticulture services; dispensing of pharmaceuticalsmedicines and supplements for the treatment of disorders of the metabolism and digestive system; dispensing of pharmaceuticalsmedicines and supplements for the treatment of rare diseases; dispensing of pharmaceuticalsmedicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; dispensing of pharmaceuticalsmedicines and supplements; dispensing of pharmaceuticalsmedicines and supplements in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; genetic testing in relation to disorders of the metabolism and digestive system; genetic testing in relation to rare diseases; genetic testing in relation to tyrosinemia and hypertyrosinemia; genetic testing for medical purposes; providing healthcare and medical information in relation to disorders of the metabolism and digestive system; providing healthcare and medical information in relation to rare diseases; providing healthcare and medical information in relation to tyrosinemia and hypertyrosinemia; providing medical product information and advisory services in relation to the treatment of disorders of the metabolism and digestive system; providing medical product information and advisory services in relation to the treatment of rare diseases; providing medical product information and advisory services in relation to the treatment of tyrosinemia and hypertyrosinemia; medicalpharmacological and pharmaceutical testing services for diagnostic and treatment purposes; medicalpharmacological and pharmaceutical testing services in relation to disorders of the metabolism and digestive system; medicalpharmacological and pharmaceutical testing services in relation to rare diseases; medicalpharmacological and pharmaceutical testing services in relation to tyrosinemia and hypertyrosinemia; providing pharmaceutical information and advisory services in relation to the treatment of disorders of the metabolism and digestive system; providing pharmaceutical information and advisory services in relation to the treatment of rare diseases; providing pharmaceutical information and advisory services in relation to the treatment of tyrosinemia and hypertyrosinemia; providing information in relation to medicalpharmacological and pharmaceutical products for the treatment of disorders of the metabolism and digestive system; providing information in relation to medicalpharmacological and pharmaceutical products for the treatment of rare diseases; providing information in relation to medicalpharmacological and pharmaceutical products for the treatment of tyrosinemia and hypertyrosinemia; providing news and information in the field of disorders of the metabolism and digestive system; providing news and information in the field of medicine in relation to tyrosinemia and hypertyrosinemia; providing news and information in the field of medicine; providing news and information in the field of rare diseases
Publicações
Histórico de despachos e eventos da marca no USPTO.
64 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/07/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/07/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
21/05/2025
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
21/05/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
15/05/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
16/04/2025
E815
TEAS SECTION 8 & 15 RECEIVED
23/01/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/04/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/04/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/04/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/04/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/03/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15/03/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15/03/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
28/10/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/05/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
02/04/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
27/02/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
26/02/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/02/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/02/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/02/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
15/02/2019
GNRT
NON-FINAL ACTION E-MAILED
15/02/2019
CNRT
SU - NON-FINAL ACTION - WRITTEN
15/02/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
14/02/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
14/02/2019
IUAF
USE AMENDMENT FILED
23/01/2019
EISU
TEAS STATEMENT OF USE RECEIVED
23/01/2019
NOAC
CORRECTED NOA E-MAILED
17/01/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
30/10/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/09/2018
PUBO
PUBLISHED FOR OPPOSITION
04/09/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/08/2018
DOCK
ASSIGNED TO EXAMINER
10/08/2018
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
01/08/2018
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
27/07/2018
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
24/07/2018
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
13/07/2018
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
12/07/2018
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
29/06/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/06/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
27/06/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
27/06/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
27/06/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
27/06/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/06/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/06/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/06/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/05/2018
GNRT
NON-FINAL ACTION E-MAILED
01/05/2018
CNRT
NON-FINAL ACTION WRITTEN
01/05/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/04/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/04/2018
ALIE
ASSIGNED TO LIE
05/04/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/03/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/12/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
14/12/2017
GNRT
NON-FINAL ACTION E-MAILED
14/12/2017
CNRT
NON-FINAL ACTION WRITTEN
14/12/2017
DOCK
ASSIGNED TO EXAMINER
14/12/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/09/2017
NWAP
NEW APPLICATION ENTERED
14/09/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NITYR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.